Good science is still the best medicine

January 15, 2004

Article

Anaheim, CA-Evidence-based medicine is at least a partial solution to many of the dilemmas facing today's ophthalmologists.

Recent Videos

EyeCon 2024: Laura M. Periman, MD, shares her passion for dry eye disease, discussing her surprising discovery of the Alpenglow Sign in Demodex blepharitis

David Eichenbaum, MD, presents advances in AMD therapy, highlights different mechanisms with a common goal

Cochair Kelly K. Nichols, OD, PhD, MPH, FAAO, highlights her passion for dry eye research and the vital collaboration between ophthalmology and optometry

Vicki Chan, MD, shares pearls for leveraging the power of social media in health care

EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future

Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology

Related Content

Tapping metabolomics for timely detection of glaucoma cases

Tapping metabolomics for timely detection of glaucoma cases

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

Physicians can use media training, public relations to combat medical misinformation

Physicians can use media training, public relations to combat medical misinformation

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Advancing the optimal diagnosis & treatment of thyroid eye disease

Clinical trial recruitment and AI: Easing the burden of GA studies

Clinical trial recruitment and AI: Easing the burden of GA studies

FDA approves faricimab-svoa 6.0 mg single-dose prefilled syringe for use in the treatment of wet AMD, DME and RVO

FDA approves faricimab-svoa 6.0 mg single-dose prefilled syringe for use in the treatment of wet AMD, DME and RVO

Related Content

Tapping metabolomics for timely detection of glaucoma cases

Tapping metabolomics for timely detection of glaucoma cases

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

Physicians can use media training, public relations to combat medical misinformation

Physicians can use media training, public relations to combat medical misinformation

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Advancing the optimal diagnosis & treatment of thyroid eye disease

Clinical trial recruitment and AI: Easing the burden of GA studies

Clinical trial recruitment and AI: Easing the burden of GA studies

FDA approves faricimab-svoa 6.0 mg single-dose prefilled syringe for use in the treatment of wet AMD, DME and RVO

FDA approves faricimab-svoa 6.0 mg single-dose prefilled syringe for use in the treatment of wet AMD, DME and RVO

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.